Does Microcurrent Increase ATP in Skin
Medically reviewed by
4 independent reviewers
Andrew Conrad Barile, Physiotherapeut, Doktor der Physiotherapie
Doktor der Physiotherapie (DPT), Lizenzierter Physiotherapeut (PT)
Read bio
Dr. Andrew Conrad Barile ist Doktor der Physiotherapie sowie CEO und Gründer von Xtreem Pulse LLC. Er erwarb seinen Doktortitel in Physiotherapie am Daemen College und bringt über zwei Jahrzehnte klinische und unternehmerische Erfahrung in der pädiatrischen Physiotherapie, Craniosacraltherapie und medizinischen Geräteinnovation mit. Sein tiefes Verständnis der menschlichen Anatomie, Muskelphysiologie und therapeutischen Technologie bietet einen wissenschaftlich fundierten Ansatz für Gesichtsverjüngung und Anti-Aging-Lösungen.
Bertica M. Rubio, M.D.
Medizinischer Direktor, Anti-Aging-Regenerationsmedizinische Klinik | Facharzt | Dartmouth Medical School
Read bio
Dr. Bertica M. Rubio ist eine zertifizierte Ärztin und medizinische Leiterin der Anti-Aging-Regenerationsklinik in Redlands, Kalifornien. Sie erwarb ihren Bachelor of Science an der Loyola Marymount University und ihren Doktortitel in Medizin an der Dartmouth Medical School (Geisel School of Medicine). Ihre Facharztausbildung in Pädiatrie absolvierte sie am UC Irvine Medical Center.
Mit jahrzehntelanger klinischer Erfahrung spezialisiert sich Dr. Rubio auf Altersmanagement, regenerative Medizin, Wundheilung und Wachstumsfaktor-Therapien. Ihre Praxis verbindet evidenzbasierte medizinische Wissenschaft mit fortschrittlichen ästhetischen und regenerativen Behandlungen, um Patienten zu optimaler Gesundheit und jugendlicher Vitalität zu verhelfen.
Dr. Rubio ist leidenschaftlich daran interessiert, Patienten über die Wissenschaft hinter Hautpflege, Gesichtsverjüngung und nicht-invasiven Technologien wie EMS (Elektrische Muskelstimulation) zur Gesichtstonung aufzuklären. Ihre Artikel für PureLift LAB verbinden fundiertes medizinisches Wissen mit praktischen Anleitungen für echte, nachhaltige Ergebnisse.
Daniel Grinberg, MD, FACS
Facharzt für Hals-Nasen-Ohren-Heilkunde und Kopf-Hals-Chirurgie | Fellow des American College of Surgeons | Assistenz-Professor für Klinische Medizin, Mount Sinai School of Medicine
Read bio
Daniel Grinberg, MD, FACS, ist ein von der Ärztekammer zertifizierter Hals-Nasen-Ohren-Arzt und Kopf-Hals-Chirurg bei ENT and Allergy Associates in West Nyack, NY. Er erwarb seinen medizinischen Abschluss an der Columbia University College of Physicians and Surgeons, absolvierte seine Facharztausbildung in Hals-Nasen-Ohren-Heilkunde am New York University Medical Center und ist Assistenzprofessor an der Mount Sinai School of Medicine. Er ist Fellow sowohl des American College of Surgeons als auch der American Academy of Otolaryngology.
Dr. Grinbergs Perspektive als Kopf-Hals-Chirurg bietet den Lesern von PureLift LAB eine erweiterte klinische Sichtweise — er verbindet die EMS-Anwendung zu Hause mit der zugrunde liegenden medizinischen Anatomie mit derselben wissenschaftlichen Genauigkeit, die wir auf jede Gerätespezifikation anwenden.
Prof. Dr. med. Ivo Buschmann
Lehrstuhl für Angiologie, Medizinische Hochschule Brandenburg | Klinikdirektor, Universitätsklinik für Angiologie, Brandenburgisches Klinikum | Ehemaliger Oberarzt, Charité Universitätsmedizin Berlin
Read bio
Prof. Dr. med. Ivo Buschmann ist Lehrstuhlinhaber für Angiologie an der Medizinischen Hochschule Brandenburg Theodor Fontane (MHB) und Klinikdirektor der Universitätsklinik für Angiologie am Brandenburgischen Universitätsklinikum. Er absolvierte seine medizinische Ausbildung an der Universität Hamburg, war Max-Planck-Gesellschaft-Stipendiat am Max-Planck-Institut für Herz- und Lungenforschung und hatte leitende Oberarztpositionen an der Charité Universitätsmedizin Berlin Campus Virchow inne, bevor er 2016 zum Lehrstuhlinhaber an der MHB berufen wurde.
Prof. Buschmann ist einer der führenden europäischen Experten für Arteriogenese – das durch Fluss angetriebene Wachstum und die Umgestaltung von Blutgefäßen – mit mehr als 150 begutachteten Veröffentlichungen und mehreren US- und EU-Patenten für Geräte, die das Wachstum von Kollateralgefäßen durch kontrollierte Scherkräfte-Therapie stimulieren. Seine Forschung verbindet mechanische und elektrische Stimulation mit vaskulärer Anpassung, Mikrozirkulation und Gewebeperfusion.
Die Beiträge von Prof. Buschmann bieten den Lesern von PureLift LAB eine gefäßbiologische Perspektive, die unsere bestehenden Autoren aus den Bereichen Klinik, Physiotherapie und chirurgische Anatomie ergänzt – und erklären, wie EMS-Stimulation nicht nur die Gesichtsmuskeln, sondern auch die Mikrozirkulation, die sie versorgt, aktiviert und warum eine intelligente Anwendung auf der Ebene des Blutflusses ebenso wichtig ist wie die Muskelkontraktion.
Teilen
One 1982 study on rat skin found ATP rose several fold at low currents and fell at higher ones, and that single paper is the source of almost every ATP claim made in this category today.
This article sets out what to check before you start, such as:
- where the 400 percent figure actually comes from
- what the 1982 study measured and in what tissue
- the detail about higher currents that nobody quotes
- why ATP is not the same as a visible result
- what we do and do not claim about our own devices
and many more!
We would rather show you the source and let you judge it than repeat a number whose origin almost nobody checks.
Key Points:
The ATP claim traces to Cheng and colleagues, published in Clinical Orthopaedics and Related Research in 1982, volume 171, pages 264 to 272.
It was performed on rat skin, not human skin, and not on a living human face.
The same study found that ATP rose at low microamp currents and decreased at currents above roughly one milliamp, which is the half nobody quotes.
ATP is cellular energy currency. More of it in a tissue sample is not the same as a visible change in a face, and no study has connected the two.
We do not make an ATP claim for our devices, because we have never measured ATP on one.
Where the number comes from
One paper, repeated for forty-four years
Search almost any microcurrent brand page and you will find a claim that the technology increases cellular energy, often stated as up to 400 percent more ATP.
Trace the citations and they converge on a single source: Cheng N, Van Hoof H, Bockx E and colleagues, The Effects of Electric Currents on ATP Generation, Protein Synthesis, and Membrane Transport of Rat Skin, Clinical Orthopaedics and Related Research, 1982, volume 171, pages 264 to 272.
That is one paper, from 1982, in an orthopedics journal, and it is carrying the mechanism story for an entire consumer category in 2026.
We are not saying it is a bad study. We are saying you should know that this is what the claim rests on.
What it actually studied
The tissue was rat skin rather than human skin, and the work was laboratory bench science rather than a clinical trial.
The context was wound healing and tissue repair, which is why it appeared in an orthopedics journal rather than a dermatology one.
Nobody in that study was trying to find out whether a jawline looked more defined after twelve weeks.
Kolimechkov and colleagues in 2023, a narrative review published in the European Journal of Applied Physiology, describes the rat skin finding as a three to five fold rise in ATP in the microamp range, which is the same source reported accurately.
The half of the finding nobody quotes
The study did not find that more current produces more ATP without limit. It found a curve.
ATP generation rose in the low microamp range and then decreased as the current was pushed higher, with the decline appearing above roughly one milliamp.
That detail matters commercially, because it argues against the idea that a stronger device produces a better cellular result. If anything it argues the opposite.
It also sits awkwardly alongside the way the figure is normally used, which is to justify buying a more powerful device. We publish our own output figures and we address this directly in our article on why more microamps do not mean better results.
Why ATP is not a result
What ATP is
Adenosine triphosphate is the molecule cells use to move energy around. Every cell in your body makes it and spends it constantly.
More ATP in a tissue sample means the cells in that sample had more available energy at the moment of measurement.
That is a biochemical observation, not a cosmetic outcome.
The gap between the two
To get from more ATP to a visibly better face, you would need a chain of evidence: ATP rises in human facial skin, that rise drives increased collagen or improved muscle function, and that change is visible and lasting.
No link in that chain has been demonstrated in a human face. The first link has not even been measured.
The strongest human finding in this field remains Kavanagh and colleagues in 2012, 108 women over twelve weeks, an 18.6 percent increase in cheek muscle thickness measured by ultrasound. That study measured muscle, not ATP, and it did not propose ATP as the mechanism.
So we have a human outcome with no mechanism attached and a rat mechanism with no human outcome attached, and the category routinely glues the two together.
What the recent reviews say
Kolimechkov and colleagues in 2023 reviewed microcurrent in exercise and sport, covering muscle adaptation, body composition and recovery. It is a narrative review rather than primary research, it concerns limbs rather than faces, and the author's own central caveat is that protocols vary so much that optimal settings cannot be identified.
Jonik and colleagues in 2025 is also a narrative review, covering clinical microcurrent for wound healing, pressure injuries and pain. It contains nothing on facial aesthetics, lifting or collagen.
Both rank on the first page of Google for people searching whether microcurrent works, which means a lot of readers are landing on papers that never studied a face.
Both are genuinely useful on safety, where they report very low rates of adverse effects, and we cite them for that in our safety article.
What we claim and what we do not
We do not claim an ATP increase for our devices. We have never measured ATP on a PureLift device and neither, as far as we can find, has any brand in this category.
What we publish instead is output. Face and Pro deliver up to 7 mA at 500 ohms, Pro Edition up to 7.7, and Pro Plus and GLOW up to 9, with a 4 microsecond pulse width and ten levels on one dial.
A figure stated at a stated load is checkable. A cellular claim borrowed from rat skin in 1982 is not.
This is the same position we take on ingredient penetration, where we cite the delivery science and state plainly that we have not measured it on our own hardware, covered in our galvanic article.
How to read any mechanism claim
Ask what tissue it was measured in. Rat skin, cell culture and human skin are three different answers.
Ask whether it was measured in a living body or in isolated tissue.
Ask what year it was published and whether anything has replicated it since.
Ask whether the outcome measured is the outcome you care about, since cellular energy and a visible jawline are not the same measurement.
We walk through this process on a real example in our article on reading a study.
Frequently asked questions
Does microcurrent really increase ATP by 400 percent
That figure traces to a 1982 study on rat skin published in Clinical Orthopaedics and Related Research. It was not measured in a human face, and no study has shown that an ATP change produces a visible cosmetic result.
What is the Cheng 1982 microcurrent study
Cheng and colleagues measured ATP generation, protein synthesis and membrane transport in rat skin under applied electrical currents. It is the single most cited source behind ATP claims in the facial device category.
Does more current mean more ATP
No. The 1982 study found ATP rose in the low microamp range and decreased at higher currents, above roughly one milliamp, which argues against the idea that a stronger device produces a better cellular result.
Is there human evidence that microcurrent increases ATP in skin
Not that we can find. The ATP work in this field is animal and laboratory based, and human facial trials have measured muscle thickness and skin appearance rather than cellular energy.
Why do brands keep citing a 1982 rat study
Because it is the only study that directly supports the cellular energy story, and no one has replaced it with human facial data in forty-four years.
This article sits inside our full map of the category, where we set out all 33 devices we track, what each one carries and what each brand publishes: Nine Technologies on One Dial, What the Rest of the Market Actually Carries.